000 01613 a2200469 4500
005 20250516160816.0
264 0 _c20141114
008 201411s 0 0 eng d
022 _a1000-467X
024 7 _a10.5732/cjc.012.10285
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGuise, Christopher P
245 0 0 _aBioreductive prodrugs as cancer therapeutics: targeting tumor hypoxia.
_h[electronic resource]
260 _bChinese journal of cancer
_cFeb 2014
300 _a80-6 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAnthraquinones
_xchemistry
650 0 4 _aAntineoplastic Agents
_xchemistry
650 0 4 _aAziridines
_xchemistry
650 0 4 _aCell Hypoxia
_xdrug effects
650 0 4 _aHumans
650 0 4 _aIndolequinones
_xchemistry
650 0 4 _aMolecular Structure
650 0 4 _aNAD(P)H Dehydrogenase (Quinone)
_xchemistry
650 0 4 _aNeoplasms
_xdrug therapy
650 0 4 _aNitrogen Mustard Compounds
_xchemistry
650 0 4 _aNitroimidazoles
_xchemistry
650 0 4 _aPhosphoramide Mustards
_xchemistry
650 0 4 _aProdrugs
_xchemistry
650 0 4 _aTirapazamine
650 0 4 _aTriazines
_xchemistry
700 1 _aMowday, Alexandra M
700 1 _aAshoorzadeh, Amir
700 1 _aYuan, Ran
700 1 _aLin, Wan-Hua
700 1 _aWu, Dong-Hai
700 1 _aSmaill, Jeff B
700 1 _aPatterson, Adam V
700 1 _aDing, Ke
773 0 _tChinese journal of cancer
_gvol. 33
_gno. 2
_gp. 80-6
856 4 0 _uhttps://doi.org/10.5732/cjc.012.10285
_zAvailable from publisher's website
999 _c22909414
_d22909414